<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34934117</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.</ArticleTitle><Pagination><StartPage>24336</StartPage><MedlinePgn>24336</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24336</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-03731-9</ELocationID><Abstract><AbstractText>ACE2 is a membrane protein that regulates the cardiovascular system. Additionally, ACE2 acts as a receptor for host cell infection by human coronaviruses, including SARS-CoV-2 that emerged as the cause of the on-going COVID-19 pandemic and has brought unprecedented burden to economy and health. ACE2 binds the spike protein of SARS-CoV-2 with high affinity and shows little variation in amino acid sequence meaning natural resistance is rare. The discovery of a novel short ACE2 isoform (deltaACE2) provides evidence for inter-individual differences in SARS-CoV-2 susceptibility and severity, and likelihood of developing subsequent 'Long COVID'. Critically, deltaACE2 loses SARS-CoV-2 spike protein binding sites in the extracellular domain, and is predicted to confer reduced susceptibility to viral infection. We aimed to assess the differential expression of full-length ACE2 versus deltaACE2 in a panel of human tissues (kidney, heart, lung, and liver) that are implicated in COVID-19, and confirm ACE2 protein in these tissues. Using dual antibody staining, we show that deltaACE2 localises, and is enriched, in lung airway epithelia and bile duct epithelia in the liver. Finally, we also confirm that a fluorescently tagged SARS-CoV-2 spike protein monomer shows low binding at lung and bile duct epithelia where dACE2 is enriched.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strachan</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, Addenbrooke's Biomedical Campus, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macrae</LastName><ForeName>Robyn G C</ForeName><Initials>RGC</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuc</LastName><ForeName>Rhoda E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyimanu</LastName><ForeName>Duuamene</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pathology, Royal Papworth Hospital NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maguire</LastName><ForeName>Janet J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Anthony P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Experimental Medicine and Immunotherapeutics, University of Cambridge, Level 6, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Box 110, Cambridge, CB2 0QQ, UK. apd10@medschl.cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_17230</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FS/13/29/30024</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>208363/Z/17/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>203814/Z/16/A</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SP/15/7/31561</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FS/17/61/33473</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT107715/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FS/18/46/33663</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001652" MajorTopicYN="N">Bile Ducts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036641" MajorTopicYN="N">Microscopy, Fluorescence, Multiphoton</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34934117</ArticleId><ArticleId IdType="pmc">PMC8692523</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-03731-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-03731-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tipnis SR, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275(43):33238&#x2013;33243. doi: 10.1074/jbc.M002615200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1&#x2013;9. Circ. Res. 2000;87(5):E1&#x2013;9. doi: 10.1161/01.res.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, et al. The emerging role of ACE2 in physiology and disease. J. Pathol. 2007;212(1):1&#x2013;11. doi: 10.1002/path.2162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2162</ArticleId><ArticleId IdType="pmc">PMC7167724</ArticleId><ArticleId IdType="pubmed">17464936</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi S, Ali BR. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: The saga continues. Hum. Genom. 2021;15(1):8. doi: 10.1186/s40246-021-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-021-00304-9</ArticleId><ArticleId IdType="pmc">PMC7844112</ArticleId><ArticleId IdType="pubmed">33514423</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell LM, Johnston CI, Tikellis C, Cooper ME. ACE2, a new regulator of the renin&#x2013;angiotensin system. Trends Endocrinol. Metab. 2004;15(4):166&#x2013;169. doi: 10.1016/j.tem.2004.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2004.03.001</ArticleId><ArticleId IdType="pmc">PMC7128798</ArticleId><ArticleId IdType="pubmed">15109615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin&#x2013;angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 2011;20(1):62&#x2013;68. doi: 10.1097/MNH.0b013e328341164a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0b013e328341164a</ArticleId><ArticleId IdType="pubmed">21099686</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822&#x2013;828. doi: 10.1038/nature00786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, et al. [Pyr1]Apelin-13(1&#x2013;12) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]Apelin-13. Front. Neurosci. 2017;11:92. doi: 10.3389/fnins.2017.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00092</ArticleId><ArticleId IdType="pmc">PMC5329011</ArticleId><ArticleId IdType="pubmed">28293165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalczuk S, et al. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 2008;22(8):2880&#x2013;2887. doi: 10.1096/fj.08-107300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-107300</ArticleId><ArticleId IdType="pubmed">18424768</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo SMR, et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009;136(3):872&#x2013;882. doi: 10.1053/j.gastro.2008.10.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.10.055</ArticleId><ArticleId IdType="pmc">PMC7094282</ArticleId><ArticleId IdType="pubmed">19185582</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo SMR, Vuille-Dit-Bille RN, Meier CF, Verrey F. ACE2 and gut amino acid transport. Clin. Sci. (Lond). 2020;134(21):2823&#x2013;2833. doi: 10.1042/CS20200477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200477</ArticleId><ArticleId IdType="pubmed">33140827</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn JH, Li W, Farzan M. Angiotensin-converting enzyme 2: A functional receptor for SARS coronavirus. Cell Mol. Life Sci. 2004;61(21):2738&#x2013;2743. doi: 10.1007/s00018-004-4242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4242-5</ArticleId><ArticleId IdType="pmc">PMC7079798</ArticleId><ArticleId IdType="pubmed">15549175</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofman H, et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U. S. A. 2005;102(22):7988&#x2013;7993. doi: 10.1073/pnas.0409465102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409465102</ArticleId><ArticleId IdType="pmc">PMC1142358</ArticleId><ArticleId IdType="pubmed">15897467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat. Commun. 2020;11(1):4541. doi: 10.1038/s41467-020-18319-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18319-6</ArticleId><ArticleId IdType="pmc">PMC7486399</ArticleId><ArticleId IdType="pubmed">32917884</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander SPH, et al. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. BJP. 2020;177(21):4942&#x2013;4966. doi: 10.1111/bph.15094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15094</ArticleId><ArticleId IdType="pmc">PMC7267163</ArticleId><ArticleId IdType="pubmed">32358833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma RK, et al. ACE2 (Angiotensin-Converting Enzyme 2) in cardiopulmonary diseases: Ramifications for the control of SARS-CoV-2. Hypertension. 2020;76(3):651&#x2013;661. doi: 10.1161/HYPERTENSIONAHA.120.15595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15595</ArticleId><ArticleId IdType="pmc">PMC7430041</ArticleId><ArticleId IdType="pubmed">32783758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2: A double-edged sword. Circulation. 2020;142(5):426&#x2013;428. doi: 10.1161/CIRCULATIONAHA.120.047049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047049</ArticleId><ArticleId IdType="pubmed">32213097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin&#x2013;angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126(10):1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TL, et al. Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection. Commun. Biol. 2021 doi: 10.1038/s42003-021-02453-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02453-y</ArticleId><ArticleId IdType="pmc">PMC8322398</ArticleId><ArticleId IdType="pubmed">34326460</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryamohan K, et al. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun. Biol. 2021 doi: 10.1038/s42003-021-02030-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02030-3</ArticleId><ArticleId IdType="pmc">PMC8041869</ArticleId><ArticleId IdType="pubmed">33846513</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, et al. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 2019;42:681&#x2013;689. doi: 10.1038/s41440-018-0166-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-018-0166-6</ArticleId><ArticleId IdType="pmc">PMC6477792</ArticleId><ArticleId IdType="pubmed">30542083</ArticleId></ArticleIdList></Reference><Reference><Citation>Malard L, et al. The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents. BMC Med. Genet. 2013 doi: 10.1186/1471-2350-14-117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-14-117</ArticleId><ArticleId IdType="pmc">PMC4228362</ArticleId><ArticleId IdType="pubmed">24191856</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro DS, et al. The combination of ACE I/D and ACE2 G8790A polymorphisms reveals susceptibility to hypertension: A genetic association study in Brazilian patients. PLoS&#xa0;One. 2019;14:e0221248. doi: 10.1371/journal.pone.0221248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221248</ArticleId><ArticleId IdType="pmc">PMC6701835</ArticleId><ArticleId IdType="pubmed">31430320</ArticleId></ArticleIdList></Reference><Reference><Citation>Patnaik M, et al. Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India. Ann. Hum. Biol. 2014;41:145&#x2013;152. doi: 10.3109/03014460.2013.837195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03014460.2013.837195</ArticleId><ArticleId IdType="pubmed">24112034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, et al. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J. Med. Virol. 2020 doi: 10.1002/jmv.25832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25832</ArticleId><ArticleId IdType="pmc">PMC7228372</ArticleId><ArticleId IdType="pubmed">32249956</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava A, et al. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India. Front. Genet. 2020 doi: 10.3389/fgene2020.564741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene2020.564741</ArticleId><ArticleId IdType="pmc">PMC7545580</ArticleId><ArticleId IdType="pubmed">33101387</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M. Resistance to HIV infection. J. Urban Health. 2006;83(1):5&#x2013;17. doi: 10.1007/s11524-005-9003-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11524-005-9003-8</ArticleId><ArticleId IdType="pmc">PMC1539443</ArticleId><ArticleId IdType="pubmed">16736351</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell LM, et al. Myocardial infarction increases ACE2 expression in rat and human. Eur. Heart J. 2005;26(4):369&#x2013;375. doi: 10.1093/eurheartj/ehi114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi114</ArticleId><ArticleId IdType="pubmed">15671045</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy JL, Lambert DW, Turner AJ, Porter KE. Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts. Exp. Physiol. 2008;93(5):579&#x2013;588. doi: 10.1113/expphysiol.2007.040139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2007.040139</ArticleId><ArticleId IdType="pubmed">18223028</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1&#x2013;2):107&#x2013;110. doi: 10.1016/S0014-5793(02)03640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(02)03640-2</ArticleId><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203(2):631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16(7):e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz ME, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. doi: 10.1016/j.ebiom.2020.102976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102976</ArticleId><ArticleId IdType="pmc">PMC7505653</ArticleId><ArticleId IdType="pubmed">32971472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 2020;202(5):756&#x2013;759. doi: 10.1164/rccm.202001-0179LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202001-0179LE</ArticleId><ArticleId IdType="pmc">PMC7462411</ArticleId><ArticleId IdType="pubmed">32663409</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Li L, Zhang Y, Wang X. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9(1):45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukassen S, et al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020;39(10):e105114. doi: 10.15252/embj.20105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.20105114</ArticleId><ArticleId IdType="pmc">PMC7232010</ArticleId><ArticleId IdType="pubmed">32246845</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tukiainen T, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550(7675):244&#x2013;248. doi: 10.1038/nature24265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24265</ArticleId><ArticleId IdType="pmc">PMC5685192</ArticleId><ArticleId IdType="pubmed">29022598</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EP, et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 2020;20:442&#x2013;447. doi: 10.1038/s41577-020-0348-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0348-8</ArticleId><ArticleId IdType="pmc">PMC7288618</ArticleId><ArticleId IdType="pubmed">32528136</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveiros A, et al. Sex differences in COVID-19: Candidate pathways, genetics of ACE2, and sex hormones. Am. J. Physiol. Heart Circ. Physiol. 2021;320(1):H296&#x2013;H304. doi: 10.1152/ajpheart.00755.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00755.2020</ArticleId><ArticleId IdType="pmc">PMC8083171</ArticleId><ArticleId IdType="pubmed">33275517</ArticleId></ArticleIdList></Reference><Reference><Citation>Onabajo OO, et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat. Genet. 2020;52(12):1283&#x2013;1293. doi: 10.1038/s41588-020-00731-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00731-9</ArticleId><ArticleId IdType="pmc">PMC9377523</ArticleId><ArticleId IdType="pubmed">33077916</ArticleId></ArticleIdList></Reference><Reference><Citation>Blume C, et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat. Genet. 2021;53:205&#x2013;214. doi: 10.1038/s41588-020-00759-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00759-x</ArticleId><ArticleId IdType="pubmed">33432184</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro AF, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021;593:564&#x2013;569. doi: 10.1038/s41586-021-03475-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03475-6</ArticleId><ArticleId IdType="pmc">PMC8204801</ArticleId><ArticleId IdType="pubmed">33780969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Shi L, Wang F. Liver injury in COVID-19: Management and challenges. Lancet Gastroenterol. Hepatol. 2020;5(5):428&#x2013;430. doi: 10.1016/S2468-1253(20)30057-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridkera PM. COVID-19&#x2014;A vascular disease. Trends Cardiovasc. Med. 2020;31(1):1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M, et al. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 2020;20(4):493&#x2013;506. doi: 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):394&#x2013;404. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira NL, et al. COVID-19: Understanding inter-individual variability and implications for precision medicine. Mayo Clin. Proc. 2020;96(2):446&#x2013;463. doi: 10.1016/j.mayocp.2020.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.11.024</ArticleId><ArticleId IdType="pmc">PMC7713605</ArticleId><ArticleId IdType="pubmed">33549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zheng S. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes. Inform. Med. Unlocked. 2020 doi: 10.1016/j.imu.2020.100443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2020.100443</ArticleId><ArticleId IdType="pmc">PMC7550072</ArticleId><ArticleId IdType="pubmed">33072849</ArticleId></ArticleIdList></Reference><Reference><Citation>Stritt M, Stalder AK, Vezzali E. Orbit image analysis: An open-source whole slide image analysis tool. PLoS Comput. Biol. 2020;16(2):e1007313. doi: 10.1371/journal.pcbi.1007313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1007313</ArticleId><ArticleId IdType="pmc">PMC7028292</ArticleId><ArticleId IdType="pubmed">32023239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods. 2012;9(7):676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>